| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
David E Cohen is Director at EVMN. David E Cohen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $104K at current prices.
The EVMN filings lean toward selling, a net 6,056 shares.
David E Cohen has 3 Form 4 filings on record from November 2025 to June 2026, all as Director at Evommune (EVMN), 2025–2026.
The 5 reported transactions were 2 open-market sales, 2 option or other derivative awards and 1 conversion.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $123K.
The only open-market sale was 6,056 shares of EVMN at an average $20.33 on June 2, 2026, about $123K.